Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Pharmacological Reports : PR|May 24, 2011
Effects of bupropion on the reinstatement of nicotine-induced conditioned place preference by drug priming in ratsBarbara Budzyńska, Grażyna Biała
Pharmacological Reports : PR|February 24, 2012
Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze testMarta Kruk, Kinga Tendera, Grażyna Biała
Brain Sciences|January 21, 2023
Recent Studies on the Development of Nicotine Abuse and Behavioral Changes Induced by Chronic Stress Depending on GenderKarolina Grabowska, Wojciech Ziemichód, Grażyna Biała
Pharmacological Reports : PR|December 15, 2012
Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in miceMarta Kruk-Słomka, Barbara Budzyńska, Grażyna Biała
Molecules (Basel, Switzerland)|September 23, 2022
A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of InsomniaWojciech Ziemichód, Karolina Grabowska, Antonina Kurowska, et al.
International Journal of Molecular Sciences|September 23, 2022
New Atypical Antipsychotics in the Treatment of Schizophrenia and DepressionJolanta Orzelska-Górka, Joanna Mikulska, Anna Wiszniewska, et al.
Pharmacological Reports : PR|June 21, 2014
A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in miceMarta Kruk-Słomka, Agnieszka Michalak, Barbara Budzyńska, et al.
Pharmacological Reports : PR|January 11, 2017
Acute behavioral effects of co-administration of mephedrone and MDMA in miceBarbara Budzynska, Agnieszka Michalak, Małgorzata Frankowska, et al.
Molecules (Basel, Switzerland)|April 28, 2023
Characteristics of Seltorexant-Innovative Agent Targeting Orexin System for the Treatment of Depression and AnxietyWojciech Ziemichód, Antonina Kurowska, Karolina Grabowska, et al.
Pageof 4